It was shown that anti-CD277 antibodies enhance anti-tumor functions of Vγ9Vδ2 T-cells in vitro (144) and in a xenotransplant mouse model of human acute myeloid leukemia (AML) (157). Here, BTN3A2 is linked to neoplasm.